One-Shot gene injection tested for severe Parkinson's
Disease control
Recruiting now
This is a very early, small study to test the safety of a new one-time gene therapy called IPS101A for people with severe, long-term Parkinson's disease. It will involve 6 participants whose symptoms are not controlled by all available medications. The main goal is to find a safe…
Phase: PHASE1 • Sponsor: Innopeutics Corporation • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC